These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616 [TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. Duarte N; Stenström M; Campino S; Bergman ML; Lundholm M; Holmberg D; Cardell SL J Immunol; 2004 Sep; 173(5):3112-8. PubMed ID: 15322171 [TBL] [Abstract][Full Text] [Related]
4. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
7. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840 [TBL] [Abstract][Full Text] [Related]
8. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. Chiu YH; Jayawardena J; Weiss A; Lee D; Park SH; Dautry-Varsat A; Bendelac A J Exp Med; 1999 Jan; 189(1):103-10. PubMed ID: 9874567 [TBL] [Abstract][Full Text] [Related]
9. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics. Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739 [TBL] [Abstract][Full Text] [Related]
10. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. Bendelac A; Hunziker RD; Lantz O J Exp Med; 1996 Oct; 184(4):1285-93. PubMed ID: 8879200 [TBL] [Abstract][Full Text] [Related]
11. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Gombert JM; Herbelin A; Tancrède-Bohin E; Dy M; Carnaud C; Bach JF Eur J Immunol; 1996 Dec; 26(12):2989-98. PubMed ID: 8977295 [TBL] [Abstract][Full Text] [Related]
13. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. Mueller R; Krahl T; Sarvetnick N J Exp Med; 1996 Sep; 184(3):1093-9. PubMed ID: 9064326 [TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors. Ellison CA; Taniguchi M; Fischer JM; Hayglass KT; Gartner JG Immunology; 2006 Nov; 119(3):338-47. PubMed ID: 16879624 [TBL] [Abstract][Full Text] [Related]
16. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086 [TBL] [Abstract][Full Text] [Related]
17. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. Wang B; Geng YB; Wang CR J Exp Med; 2001 Aug; 194(3):313-20. PubMed ID: 11489950 [TBL] [Abstract][Full Text] [Related]
18. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production. Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646 [TBL] [Abstract][Full Text] [Related]
19. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. Arnold PY; Burton AR; Vignali DA J Immunol; 2004 Sep; 173(5):3103-11. PubMed ID: 15322170 [TBL] [Abstract][Full Text] [Related]
20. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]